Andersch, S, Hetta, J (2003) A 15-year follow-up study of patients with panic disorder. European Psychiatry
Balter, MB, Levine, J, Manheimer, D (1974) Cross-national study of the extent of anti-anxiety/sedative drug use. New England Journal of Medicine
Barbone, F, McMahon, AD, Davey, PG et al (1998) Association of road-traffic accidents with benzodiazepine use. Lancet
Barker, MJ, Greenwood, KM, Jackson, M et al (2004) Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs
Biondi, M, Picardi, A (2003) Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study. Psychotherapy and Psychosomatics
Bruce, SE, Vasile, RG, Goisman, RM et al (2003) Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?
American Journal of Psychiatry
Busto, UE, Bremner, KE, Knight, K et al (2000) Long-term benzodiazepine therapy does not result in brain abnormalities. Journal of Clinical Psychopharmacology
Cowley, DS, Ha, EH, Roy-Byrne, PP (1997) Determinants of pharmacologic treatment failure in panic disorder. Journal of Clinical Psychiatry
Cross-National Collaborative Panic Study, Second Phase Investigators (1992) Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. British Journal of Psychiatry
Davidson, JRT, Petts, N, Richichi, E et al (1993) Treatment of social phobia with clonazepam and placebo. Journal of Clinical Psychopharmacology
Deckersbach, T, Moshier, SJ, Tuschen-Caffier, B et al (2011) Memory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use. Depression and Anxiety
Demyttenaere, K, Bonnewyn, A, Bruffaerts, R et al (2008) Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). Journal of Affective Disorders
Freeman, SA (2009) The benzodiazepine stigma persists. Journal of Clinical Psychiatry
Gelernter, CS, Uhde, TW, Cimbolic, P et al (1991) Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Archives of General Psychiatry
Goddard, AW, Brouette, T, Almai, A et al (2001) Early coadministration of clonazepam with sertraline for panic disorder. Archives of General Psychiatry
Haefely, W (1986) Biological basis of drug-induced tolerance, rebound, and dependence: contribution of recent research on benzodiazepines. Pharmacopsychiatry
Healy, D (2002) Psychiatric Drugs Explained. Third Edition
142. Churchill Livingstone.
Lucki, I, Rickels, K, Geller, AM (1986) Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berlin)
Mol, AJJ, Gorgels, WJMJ, Voshaar, RCO et al (2005) Associations of benzodiazepine craving with other clinical variables in a population of general practice patients. Comprehensive Psychiatry
Nagy, LM, Krystal, JH, Woods, SW et al (1989) Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder: 2.5 year naturalistic follow-up study. Archives of General Psychiatry
Noyes, R, Garvey, MJ, Cook, B (1991) Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry
O'Brien, CP (2005) Benzodiazepine use, abuse, and dependence. Journal of Clinical Psychiatry
66 (suppl 2): 28–33.
Otto, MW, Pollack, MH, Sachs, GS et al (1993) Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry
Pollack, MH, Otto, MW, Tesar, GE et al (1993) Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. Journal of Clinical Psychopharmacology
Pollack, MH, Simon, NM, Worthington, JJ et al (2003) Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. Journal of Psychopharmacology
Pradel, V, Delga, C, Rouby, F et al (2010) Assessment of abuse potential of benzodiazepines from a prescription database using “doctor shopping” as an indicator. CNS Drugs
Rapoport, MJ, Lanctot, KL, Streiner, DL et al (2009) Benzodiazepine use and driving: a meta-analysis. Journal of Clinical Psychiatry
Rickels, K, Downing, R, Schweizer, E et al (1993) Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone, and diazepam. Archives of General Psychiatry
Rickels, K, DeMartinis, N, Aufdembrinke, B (2000) A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder. Journal of Clinical Psychopharmacology
Rosenbaum, JF, Moroz, G, Bowden, CL (1997) Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Journal of Clinical Psychopharmacology
Rosenbaum, JF (2005) Attitudes toward benzodiazepines over the years. Journal of Clinical Psychiatry
66 (suppl 2): 4–8.
Rothschild, AJ, Shindul-Rothschild, J, Viguera, A et al (2000) Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients. Journal of Clinical Psychopharmacology
Salzman, C (1991) The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. American Journal of Psychiatry
Salzman, C, Miyawaki, EK, le Bars, P et al (1993) Neurobiologic basis of anxiety and its treatment. Harvard Review of Psychiatry
Schweizer, E, Rickels, K, Weiss, S et al (1993) Maintenance drug treatment of panic disorder: I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Archives of General Psychiatry
Shader, RI, Greenblatt, DJ (1993) Use of benzodiazepines in anxiety disorders. New England Journal of Medicine
Smolders, M, Laurant, M, van Rijswijk, E et al (2007) The impact of comorbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder. Family Practice
Soumerai, SB, Simoni-Wastila, L, Singer, C et al (2003) Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatric Services
Spiegel, DA, Bruce, TJ, Gregg, SF et al (1994) Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
American Journal of Psychiatry
Stahl, SM (2002) Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. Journal of Clinical Psychiatry
Starcevic, V (2011) Have anxiety disorders been disowned by psychiatrists?
Uhlenhuth, EH, Balter, MB, Ban, TA et al (1999) International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. Journal of Clinical Psychopharmacology
19 (suppl 2): 23-29S.
Vasile, RG, Bruce, SE, Goisman, RM et al (2005) Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depression and Anxiety
Wagner, AK, Ross-Degnan, D, Gurwitz, JH et al (2007) Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Annals of Internal Medicine
Worthington, JJ, Pollack, MH, Otto, MW et al (1998) Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacology Bulletin